39,006 Shares in Encompass Health Corporation $EHC Purchased by Moran Wealth Management LLC

Moran Wealth Management LLC acquired a new position in shares of Encompass Health Corporation (NYSE:EHC) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 39,006 shares of the company’s stock, valued at approximately $4,783,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in EHC. WPG Advisers LLC bought a new position in shares of Encompass Health in the first quarter worth approximately $27,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in shares of Encompass Health by 749.0% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company’s stock worth $42,000 after buying an additional 367 shares in the last quarter. Arlington Trust Co LLC lifted its stake in shares of Encompass Health by 22.9% in the first quarter. Arlington Trust Co LLC now owns 671 shares of the company’s stock worth $68,000 after buying an additional 125 shares in the last quarter. Park Place Capital Corp bought a new position in shares of Encompass Health in the second quarter worth approximately $72,000. Finally, Caitong International Asset Management Co. Ltd lifted its stake in shares of Encompass Health by 19.0% in the first quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company’s stock worth $73,000 after buying an additional 115 shares in the last quarter. Institutional investors own 97.25% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently issued reports on EHC shares. Bank of America upped their target price on shares of Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a research note on Wednesday, September 10th. UBS Group boosted their price objective on shares of Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a report on Thursday, October 2nd. Truist Financial boosted their price objective on shares of Encompass Health from $135.00 to $140.00 and gave the company a “buy” rating in a report on Thursday, August 14th. Weiss Ratings reissued a “buy (b+)” rating on shares of Encompass Health in a report on Wednesday, October 8th. Finally, KeyCorp boosted their price objective on shares of Encompass Health from $135.00 to $140.00 and gave the company an “overweight” rating in a report on Tuesday, September 16th. One investment analyst has rated the stock with a Strong Buy rating and eight have issued a Buy rating to the company’s stock. According to MarketBeat, Encompass Health currently has a consensus rating of “Buy” and an average target price of $139.86.

Insider Buying and Selling

In other Encompass Health news, EVP Patrick William Tuer sold 1,020 shares of the company’s stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the completion of the sale, the executive vice president directly owned 18,846 shares of the company’s stock, valued at approximately $2,329,177.14. This represents a 5.13% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 2.10% of the company’s stock.

Encompass Health Stock Up 1.4%

Shares of EHC stock opened at $122.95 on Wednesday. Encompass Health Corporation has a 12 month low of $87.85 and a 12 month high of $127.86. The stock has a market cap of $12.38 billion, a P/E ratio of 24.06, a P/E/G ratio of 2.12 and a beta of 0.93. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.76. The company has a 50 day simple moving average of $123.14 and a two-hundred day simple moving average of $116.80.

Encompass Health (NYSE:EHC) last announced its earnings results on Wednesday, March 16th. The company reported $0.93 EPS for the quarter. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. The business had revenue of $136.30 million during the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. On average, research analysts expect that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be issued a dividend of $0.19 per share. This is an increase from Encompass Health’s previous quarterly dividend of $0.17. This represents a $0.76 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Wednesday, October 1st. Encompass Health’s dividend payout ratio is currently 14.87%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.